Dr. Rekha Kumar
Pills vs. Needles: The New Frontier in Weight Loss and Hormone Therapy
What if the future of weight loss, metabolic health, and longevity isn’t defined by the next breakthrough medication alone — but by how thoughtfully we improve access, personalize care, and rethink the way we support the human body across the lifespan? As science advances and new therapies emerge, the real opportunity may lie in integrating innovation with foundational habits, compassionate clinical guidance, and a deeper understanding of how metabolism, hormones, and mindset shape long-term wellbeing.
In this episode, we sit down with endocrinologist and obesity medicine specialist Dr. Rekha Kumar to explore the rapidly evolving science of GLP-1 therapies, the shift toward oral treatment options, and the broader landscape of hormone health and metabolic resilience. Together, we unpack the practical realities of prescribing, the challenges of affordability and access, and the evidence-based strategies that can help individuals pursue sustainable health optimization in a complex and often confusing wellness environment.
Episode Overview
Together, we explore how science and lived experience intersect within the human ecology of metabolism, resilience, and performance. Dr. Kumar helps us unpack the shift from injectable to oral GLP-1 medications, the real-world challenges of medication access and off-label prescribing, and how emerging delivery technologies may reshape treatment pathways.
We also examine the deeper drivers of metabolic dysfunction — including hormonal changes, muscle loss, insulin resistance, and social stigma — while emphasizing the importance of individualized care. This conversation offers a grounded, science-informed perspective on weight management, hormone therapy in women, and the mindset shifts required for lasting health and longevity.
What You’ll Learn in This Episode
• Why oral GLP-1 medications may transform access to obesity treatment
• The science behind SNAC technology and oral drug absorption
• Microdosing strategies and personalization in metabolic care
• Psychological and cultural barriers surrounding injectable therapies
• Off-label prescribing realities and insurance limitations
• Broader metabolic and cardiovascular benefits of GLP-1 medications
• How hormonal shifts influence weight, energy, and disease risk
• The role of muscle mass — especially glute strength — in glucose metabolism
• Practical considerations for testosterone therapy in women
• Why lifestyle foundations remain essential alongside medication
• How patient-provider collaboration supports long-term resilience
About Our Guest
Dr. Rekha Kumar is an internationally recognized leader in Obesity Medicine, passionately committed to addressing the U.S. obesity epidemic by making high-quality care affordable and accessible.
As Senior Medical Advisor at Found since 2021, Dr. Kumar has combined her medical expertise with innovative technology to deliver personalized weight management solutions. Under her leadership, Found’s platform integrates the latest medical research and clinical practices, ensuring that users receive evidence-based, effective treatments. Dr. Kumar believes that obesity is a disease that has been underserved in America, and by bringing together the top clinicians in the space, the latest technology, and business practices, we can fi nally solve one of America’s longest-running epidemics.
Beyond her role at Found, Dr. Kumar practices endocrinology at NewYork-Presbyterian in New York City, where she merges traditional medical practice with digital health innovations. This dual role allows her to bridge the gap between established healthcare methods and emerging technologies, enhancing the reach and effectiveness of obesity treatment. Her work at the intersection of medicine and business has positioned her as a key figure in advancing Obesity Medicine.
Dr. Kumar completed her undergraduate studies at Duke University then received her master’s degree in Physiology from Georgetown University. She continued to receive her M.D. from New York Medical College and completed her residency training in Internal Medicine at NewYork-Presbyterian Hospital/Weill-Cornell Medical College. Dr. Kumar obtained her clinical fellowship in the combined Diabetes, Endocrinology, and Metabolism program at the Weill-Cornell Medical College/New York Presbyterian Hospital and the Memorial Sloan Kettering Cancer Center.
She has traveled abroad to India, China, and Tanzania to understand the scope of metabolic disease globally. She serves on the board of advisors of the Duke Global Health Institute and is Board-Certifi ed in Internal Medicine, Endocrinology, Diabetes, and Metabolism, as well as Obesity Medicine.
Follow Dr. Kumar here:
LinkedIn: https://www.linkedin.com/in/rekha-kumar-m-d-m-s-70b481237/
Instagram: https://www.instagram.com/drrekhakumar/
For information about Found visit: https://joinfound.com/
Instagram: https://www.instagram.com/joinfound/
LinkedIn: https://www.linkedin.com/company/foundhealth/
⏱ Episode Timestamps
00:00:00 — GLP-1 Microdosing & Off-Label Challenges
00:01:05 — Testosterone Prescribing for Women
00:01:54 — Guest Introduction: Dr. Rekha Kumar
00:02:33 — Shift to Oral GLP-1 Medications
00:04:41 — Who Should Consider GLP-1 Therapy?
00:07:39 — Medication Access: Cost, Speed & Convenience
00:09:12 — Psychological Barriers to Injections
00:13:01 — How Oral GLP-1s Work (SNAC Technology)
00:21:54 — Oral GLP-1 Dosing & Administration Tips
00:23:01 — GLP-1 Benefits Beyond Weight Loss
00:25:26 — Understanding Off-Label Prescribing
00:27:45 — Insurance Barriers & Coverage Issues
00:30:01 — When GLP-1s Don’t Deliver Results
00:32:16 — Personalizing GLP-1 Microdosing
00:35:01 — Pharmacy Limitations & Protocol Logistics
00:36:20 — Testosterone Prescribing Workarounds
00:39:13 — Testosterone Delivery Risks & Options
00:41:57 — Monitoring Hormone Therapy in Women
00:45:38 — When to Start Tracking Hormonal Health
00:50:22 — Metabolic Disease & Women’s Health Bias
00:53:02 — Glucose, Brain Health & GLP-1s
00:55:21 — Muscle Mass, Metabolism & Glute Strength
00:58:43 — Key Takeaways & Episode Wrap-Up